Gemin X raises $16 million

Gemin X Pharmaceuticals Inc. (Malvern, Pa.) raised $16 million in a series D round co-led by existing investors Caxton Advantage Life Sciences Fund and Sanderling Venture Partners. Gemin X's obatoclax...